The US Food and Drug Administration’s Office of Prescription Drug Promotion announced its second research project of the year, which builds on previous research on market claims and disclosures and is one of its most expensive with a price tag of $722,644.
The new project, “Adherence Potential and Patient Preferences in Prescription Drug Promotion,” will assess the influence of statements around patient...